Published in Tissue Eng on September 14, 2004
Intrinsic tissue fluorescence in an organotypic perfusion culture of the porcine ocular fundus exposed to blue light and free radicals. Graefes Arch Clin Exp Ophthalmol (2008) 0.77
Supportive development of functional tissues for biomedical research using the MINUSHEET® perfusion system. Clin Transl Med (2012) 0.77
Bridging the gap between traditional cell cultures and bioreactors applied in regenerative medicine: practical experiences with the MINUSHEET perfusion culture system. Cytotechnology (2015) 0.75
A defined range of guard cell calcium oscillation parameters encodes stomatal movements. Nature (2001) 2.82
Alteration of stimulus-specific guard cell calcium oscillations and stomatal closing in Arabidopsis det3 mutant. Science (2000) 2.80
Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol (2001) 2.68
Experiencing transitions: an emerging middle-range theory. ANS Adv Nurs Sci (2000) 2.00
Comparative sequence analysis reveals extensive microcolinearity in the lateral suppressor regions of the tomato, Arabidopsis, and Capsella genomes. Plant Cell (2001) 1.79
Regional chemotherapy in liver metastases of colorectal carcinoma: monitoring with arterial computed tomography. Cancer Invest (1990) 1.40
Effect of D-penicillamine on lymphocyte function. Arzneimittelforschung (1975) 1.38
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial. J Cancer Res Clin Oncol (1988) 1.19
Influence of temperature during cardiopulmonary bypass on leukocyte activation, cytokine balance, and post-operative organ damage. Shock (2001) 1.01
The influence of urea on protein synthesis of stimulated lymphocytes. Klin Wochenschr (1972) 0.96
Clinical pharmacology of two specific bradycardiac agents. Eur Heart J (1987) 0.95
[The demonstration and identification of a factor of the nature of immune globulin M and the antibody properties in the serum of patients with multiple sclerosis]. Klin Wochenschr (1965) 0.95
The production of pro- and anti-inflammatory cytokines in neonates assessed by stimulated whole cord blood culture and by plasma levels at birth. Biol Neonate (1998) 0.94
Synthesis of spherical porous silicas in the micron and submicron size range: challenges and opportunities for miniaturized high-resolution chromatographic and electrokinetic separations. J Chromatogr A (2000) 0.94
Influence of D-penicillamine on the immune response of mice. Arzneimittelforschung (1975) 0.93
A lymphocyte-inhibiting factor isolated from normal human liver. Nature (1974) 0.92
Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism. J Clin Oncol (1997) 0.92
Cocaine- and amphetamine-regulated transcript stimulates colonic motility via central CRF receptor activation and peripheral cholinergic pathways in fed, conscious rats. Neurogastroenterol Motil (2004) 0.91
Proliferating cells versus differentiated cells in tissue engineering. Tissue Eng (2002) 0.90
Increased expression of Thomsen-Friedenreich antigens during tumor progression in breast cancer patients. Tumour Biol (1988) 0.89
Potential of stem/progenitor cell cultures within polyester fleeces to regenerate renal tubules. Biomaterials (2009) 0.88
[The treatment of chronic aggressive hepatitis with D-penicillamine]. Dtsch Med Wochenschr (1971) 0.88
[Quantitative behavior of immunoglobulins in chronic inflammatory liver diseases]. Klin Wochenschr (1969) 0.87
Dietary salt intake modulates differential splicing of the Na-K-2Cl cotransporter NKCC2. Am J Physiol Renal Physiol (2013) 0.86
Role of renocortical cyclooxygenase-2 for renal vascular resistance and macula densa control of renin secretion. J Am Soc Nephrol (2001) 0.86
Moderate hypothermia during cardiopulmonary bypass reduces myocardial cell damage and myocardial cell death related to cardiac surgery. J Am Coll Cardiol (2001) 0.85
Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: crystallographic, kinetic, and spectroscopic studies. J Med Chem (1999) 0.85
Keyhole limpet hemocyanin (KLH) conjugate vaccines as novel therapeutic tools in malignant disorders. J Cancer Res Clin Oncol (2001) 0.84
Longitudinal development of distress, coping and quality of life in HIV-positive persons. Psychother Psychosom (1997) 0.83
[Demonstration of circulating autoantibodies in progressive chronic hepatitis]. Klin Wochenschr (1968) 0.83
Failure of naloxone to reduce self-injurious behavior in two developmentally disabled females. Appl Res Ment Retard (1986) 0.83
Long-term maintenance of human articular cartilage in culture for biomaterial testing. Biomaterials (2005) 0.83
Bradycardia and hypotension associated with baclofen used during general anesthesia. Anesthesiology (1986) 0.82
Identification of the apparently lymphocyte-specific human liver-derived inhibitory protein (LIP) as cytoplasmic liver L-arginase. J Immunol (1983) 0.82
[On the question of drug-induced pseudo-LE syndrome: preliminary results in 58 cases (author's transl)]. Dtsch Med Wochenschr (1975) 0.82
Modulating the development of renal tubules growing in serum-free culture medium at an artificial interstitium. Tissue Eng (2007) 0.81
Purification and biochemical characterization of human liver-derived inhibitory protein (LIP). J Immunol (1983) 0.81
Immunohistochemical localisation of arginase in human liver using monoclonal antibodies against human liver arginase. Histochemistry (1987) 0.81
Interaction of peanut agglutinin with human lymphocytes. Binding properties and topology of the receptor site. Z Immunitatsforsch Immunobiol (1978) 0.81
Gender differences in emotional disability and negative health perception in cardiac patients 6 months after stent implantation. J Psychosom Res (2000) 0.81
Influence of sequential exposure to R-verapamil or B8509-035 on rhodamine 123 accumulation in human lymphoblastoid cell lines. Cancer Chemother Pharmacol (1993) 0.80
High concentration of soluble HLA-DR in the synovial fluid: generation and significance in "rheumatoid-like" inflammatory joint diseases. Cell Immunol (2000) 0.80
Ca(2+)-dependent desensitization of insulin secretion by strong potassium depolarization. Am J Physiol Endocrinol Metab (2012) 0.80
Studies on Miltenberger class III, V, Mv and Mk red cells. I. Sodium-dodecylsulfate polyacrylamide gel electrophoretic investigations. Blut (1978) 0.80
Purification, affinity to anti-human arginase immunoglobulin-Sepharose 4B and subunit molecular weights of mammalian arginases. Biochim Biophys Acta (1985) 0.79
Reproducibility of one-stage, two-stage and chromogenic assays of factor VIII activity: a multi-center study. Thromb Res (1991) 0.79
Specificity of reagents directed to the Thomsen-Friedenreich antigen and their capacity to bind to the surface of human carcinoma cell lines. Cancer Res (1986) 0.79
SBA-positive fibers between the CD ampulla, mesenchyme, and renal capsule. J Am Soc Nephrol (2002) 0.79
Tridacnin, a new mitogenic lectin from invertebrate sources. Z Immunitatsforsch Immunobiol (1977) 0.79
Modulation of cell differentiation in perfusion culture. Exp Nephrol (1999) 0.79
Characterization of Thomsen-Friedenreich antibody subpopulations from normal human serum. Tumour Biol (1987) 0.79
Detection of glycosylated sites in embryonic rabbit kidney by lectin chemistry. Histochem Cell Biol (2002) 0.79
Neurofibrillary pathology in progressive supranuclear palsy (PSP). J Neural Transm Suppl (1994) 0.78
[Moschcowitz-syndrome. A contribution on the "thrombotic thrombopenic purpura" with coagulation-physiological and pathologic-anatomical studies]. Dtsch Med Wochenschr (1969) 0.78
Specific T-cell marking by Helix pomatia agglutinin after neuraminidase treatment. Klin Wochenschr (1973) 0.78
Pharmacokinetics and biodisposition of recombinant human interferon-alpha 2C in rat and marmoset. Arzneimittelforschung (1988) 0.78
Cyclooxygenases in the collecting duct of neonatal rabbit kidney. Cell Physiol Biochem (2002) 0.78
Competitive nested polymerase chain reaction for quantification of human MDR1 gene expression. J Cancer Res Clin Oncol (1994) 0.77
Fractionated administration of high-dose cyclophosphamide: influence on dose-dependent changes in pharmacokinetics and metabolism. Cancer Chemother Pharmacol (1999) 0.77
Insulinotropic effect of high potassium concentration beyond plasma membrane depolarization. Am J Physiol Endocrinol Metab (2014) 0.77
[Problems in transplantation immunology]. Z Immunitatsforsch Allerg Klin Immunol (1967) 0.77
The formation of pores in the basal lamina of regenerated renal tubules. Biomaterials (2008) 0.77
Detection of lymphocytes with increased DNA-synthesis in the peripheral blood of patients with active chronic hepatitis. Klin Wochenschr (1974) 0.77
Dexverapamil to overcome epirubicin resistance in advanced breast cancer. J Cancer Res Clin Oncol (1995) 0.77
Pharmacokinetics of two pasteurized factor VIII concentrates by different and multicenter assays of factor VIII activity. Thromb Res (1992) 0.76
Tissue factory: conceptual design of a modular system for the in vitro generation of functional tissues. Tissue Eng (2004) 0.76
Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines. Eur J Clin Pharmacol (1991) 0.76
Advanced technique for long term culture of epithelia in a continuous luminal-basal medium gradient. Biomaterials (2002) 0.76
Temporal-spatial co-localisation of tissue transglutaminase (Tgase2) and matrix metalloproteinase-9 (MMP-9) with SBA-positive micro-fibres in the embryonic kidney cortex. Cell Tissue Res (2005) 0.76
Long term culture of epithelia in a continuous fluid gradient for biomaterial testing and tissue engineering. J Biomater Sci Polym Ed (2001) 0.76
[Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04]. Strahlenther Onkol (2000) 0.75
Association studies of Parkinson's disease and parkin polymorphisms. Ann Neurol (2000) 0.75
Interaction of myelin basic protein with mononuclear cells: the primary reaction for the MEM and EMT tests. Br J Cancer (1981) 0.75
Chemically defined medium environment for the development of renal stem cells into tubules. Biotechnol J (2007) 0.75
[Basis of immunosuppressive effect of D-penecillamine]. Internist (Berl) (1975) 0.75
[The planning of therapeutic trials in leukemias]. Methods Inf Med (1962) 0.75
[Comparative study on the detection of antinuclear antibodies with special reference to disseminated lupus erythematosus]. Verh Dtsch Ges Inn Med (1978) 0.75
[So-called unconventional cancer therapy]. Med Klin (Munich) (1986) 0.75
[Passive prophylactic immunisation against post-transfusion hepatitis by immunoglobulin preparations: a prospective clinical study]. Dtsch Med Wochenschr (1982) 0.75
Comparison of Factor VIII concentrates in non-bleeding patients. Scand J Haematol Suppl (1984) 0.75
[Studies on the mechanism of action of D-penicillamine (DPA) on human lymphocytes (author's transl)]. Arzneimittelforschung (1980) 0.75
[Immune defective states in tumor patients]. Verh Dtsch Ges Inn Med (1980) 0.75
[In vivo activated null cells in acute chronic hepatitis]. Verh Dtsch Ges Inn Med (1978) 0.75
[Therapy with immunoglobulins]. Med Monatsschr Pharm (1987) 0.75
Inhibition of homotypic aggregation of a human Burkitt-lymphoma cell line. Int J Cancer (1987) 0.75
[Therapy with immunoglobulins]. Dtsch Med Wochenschr (1986) 0.75
[Transfer factor (TF) treatment of patients with HBs-Ag-positive chronic active hepatitis. A prospective, controlled study (author's transl)]. Klin Wochenschr (1979) 0.75
A critical examination of intra-agency relocation effects. Appl Res Ment Retard (1986) 0.75
[In vivo reactivation of reduced T cell activity following polytransfusion caused by immune aggregates in immunoglobulin preparations]. Immun Infekt (1985) 0.75
[Changes in blood lymphocytes and their subpopulation in patients with myeloblastic leukemia treated with cytostatic agents]. Acta Haematol Pol (1979) 0.75
VBAMDex chemotherapy in advanced multiple myeloma. Eur J Haematol (1988) 0.75
Dynamic models for animal orientation. J Math Biol (1980) 0.75
[Immunosuppressive therapy]. Internist (Berl) (1984) 0.75
[Tumor genes. A demonstrable cause of malignant growth]. ZFA (Stuttgart) (1983) 0.75
[Disorders in the resistance to infections]. Verh Dtsch Ges Inn Med (1978) 0.75
Concurrent validity of the behavior development survey. Am J Ment Defic (1983) 0.75
[Diagnosis of autoimmune diseases based on laboratory parameters]. Med Welt (1982) 0.75
[Circulating immune complexes and complement factors in patients following cardiosurgical operations]. Immun Infekt (1985) 0.75
Epstein-Barr virus infections in childhood. Acta Virol (1979) 0.75
[Recent advances in oncology. From the viewpoint of the internal oncologist]. ZFA (Stuttgart) (1983) 0.75